A multicellular 3D heterospheroid model of liver tumor and stromal cells in collagen gel for anti-cancer drug testing

Biochemical and Biophysical Research Communications

Volumn 433, Issue 3, 2013, Pages 327-332

  Yip, Derek ^a   Cho, Cheul H ^a  

^a NEW JERSEY INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

Collagen hydrogel; Doxorubicin; Hanging drop method; Liver cancer; Stromal fibroblasts; Three dimensional

Indexed keywords

ANTINEOPLASTIC AGENT; COLLAGEN GEL;

ARTICLE; COCULTURE; CONTROLLED STUDY; ENCAPSULATION; EXTRACELLULAR MATRIX; FIBROBLAST; HUMAN; HUMAN CELL; HYDROGEL; IN VIVO STUDY; LIVER CELL CARCINOMA; PRIORITY JOURNAL; STROMA CELL; TUMOR MICROENVIRONMENT;

ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; CARCINOMA; CELL LINE; COCULTURE TECHNIQUES; COLLAGEN; DOXORUBICIN; EXTRACELLULAR MATRIX; FIBROBLASTS; HEP G2 CELLS; HUMANS; HYDROGELS; LIVER NEOPLASMS; MICE; MICROSCOPY, FLUORESCENCE; MITOMYCIN; MOLECULAR CONFORMATION; SPHEROIDS, CELLULAR; STROMAL CELLS; TISSUE SCAFFOLDS;

EID: 84876320133     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2013.03.008     Document Type: Article

References (21)

1. DiMasi J.A., Hansen R.W., Grabowski H.G. The price of innovation: new estimates of drug development costs. J. Health Econ. 2003, 22:151-185.
2. Knobloch J., Ruther U. Shedding light on an old mystery: thalidomide suppresses survival pathways to induce limb defects. Cell Cycle 2008, 7:1121-1127.
3. Chang T.T., Hughes-Fulford M. Monolayer and spheroid culture of human liver hepatocellular carcinoma cell line cells demonstrate distinct global gene expression patterns and functional phenotypes. Tissue Eng. Part A 2009, 15:559-567.
4. Hirschhaeuser F., Menne H., Dittfeld C., West J., Mueller-Klieser W., Kunz-Schughart L.A. Multicellular tumor spheroids: an underestimated tool is catching up again. J. Biotechnol. 2010, 148:3-15.
5. Lecluyse E.L., Witek R.P., Andersen M.E., Powers M.J. Organotypic liver culture models: meeting current challenges in toxicity testing. Crit. Rev. Toxicol. 2012, 42:501-548.
6. Pampaloni F., Stelzer E.H., Masotti A. Three-dimensional tissue models for drug discovery and toxicology. Recent Pat. Biotechnol. 2009, 3:103-117.
7. Chia S.M., Lin P.C., Yu H. TGF-beta1 regulation in hepatocyte-NIH3T3 co-culture is important for the enhanced hepatocyte function in 3D microenvironment. Biotechnol. Bioeng. 2005, 89:565-573.
8. Brophy C.M., Luebke-Wheeler J.L., Amiot B.P., Khan H., Remmel R.P., Rinaldo P., Nyberg S.L. Rat hepatocyte spheroids formed by rocked technique maintain differentiated hepatocyte gene expression and function. Hepatology 2009, 49:578-586.
9. Verma P., Verma V., Ray P., Ray A.R. Formation and characterization of three dimensional human hepatocyte cell line spheroids on chitosan matrix for in vitro tissue engineering applications. In Vitro Cell. Dev. Biol. Anim. 2007, 43:328-337.
10. Desoize B., Jardillier J. Multicellular resistance: a paradigm for clinical resistance?. Crit. Rev. Oncol. Hematol. 2000, 36:193-207.
11. Gwak S.J., Choi D., Paik S.S., Cho S.W., Kim S.S., Choi C.Y., Kim B.S. A method for the effective formation of hepatocyte spheroids using a biodegradable polymer nanosphere. J. Biomed. Mater. Res., A 2006, 78:268-275.
12. Lee K.W., Lee S.K., Joh J.W., Kim S.J., Lee B.B., Kim K.W., Lee K.U. Influence of pancreatic islets on spheroid formation and functions of hepatocytes in hepatocyte-pancreatic islet spheroid culture. Tissue Eng. 2004, 10:965-977.
13. Friedrich J., Ebner R., Kunz-Schughart L.A. Experimental anti-tumor therapy in 3-D: spheroids-old hat or new challenge?. Int. J. Radiat. Biol. 2007, 83:849-871.
14. Kojima N., Takeuchi S., Sakai Y. Establishment of self-organization system in rapidly formed multicellular heterospheroids. Biomaterials 2011, 32:6059-6067.
15. Nakazawa K., Lee S.W., Fukuda J., Yang D.H., Kunitake T. Hepatocyte spheroid formation on a titanium dioxide gel surface and hepatocyte long-term culture. J. Mater. Sci. - Mater. Med. 2006, 17:359-364.
16. S.F. Wong, Y. No da, Y.Y. Choi, D.S. Kim, B.G. Chung, S.H. Lee, Concave microwell based size-controllable hepatosphere as a three-dimensional liver tissue model, Biomaterials 32 (2011), 8087-8096.
17. Yang J.D., Nakamura I., Roberts L.R. The tumor microenvironment in hepatocellular carcinoma: current status and therapeutic targets. Semin. Cancer Biol. 2011, 21:35-43.
18. Wu X.Z., Xie G.R., Chen D. Hypoxia and hepatocellular carcinoma: the therapeutic target for hepatocellular carcinoma. J. Gastroenterol. Hepatol. 2007, 22:1178-1182.
19. Cho C.H., Berthiaume F., Tilles A.W., Yarmush M.L. A new technique for primary hepatocyte expansion in vitro. Biotechnol. Bioeng. 2008, 101:345-356.
20. Schrader J., Gordon-Walker T.T., Aucott R.L., van Deemter M., Quaas A., Walsh S., Benten D., Forbes S.J., Wells R.G., Iredale J.P. Matrix stiffness modulates proliferation, chemotherapeutic response, and dormancy in hepatocellular carcinoma cells. Hepatology 2011, 53:1192-1205.
21. Yasuda H. Solid tumor physiology and hypoxia-induced chemo/radio-resistance. novel strategy for cancer therapy: nitric oxide donor as a therapeutic enhancer. Nitric Oxide 2008, 19:205-216.